Theravance Biopharma Statistics
Total Valuation
TBPH has a market cap or net worth of $939.97 million. The enterprise value is $651.86 million.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TBPH has 50.67 million shares outstanding. The number of shares has increased by 3.49% in one year.
| Current Share Class | 50.67M |
| Shares Outstanding | 50.67M |
| Shares Change (YoY) | +3.49% |
| Shares Change (QoQ) | +2.33% |
| Owned by Insiders (%) | 7.16% |
| Owned by Institutions (%) | 47.87% |
| Float | 22.36M |
Valuation Ratios
The trailing PE ratio is 31.97 and the forward PE ratio is 26.66.
| PE Ratio | 31.97 |
| Forward PE | 26.66 |
| PS Ratio | 11.53 |
| Forward PS | 8.17 |
| PB Ratio | 4.04 |
| P/TBV Ratio | 4.04 |
| P/FCF Ratio | 3.86 |
| P/OCF Ratio | 3.86 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 22.21 |
| EV / Sales | 8.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.68 |
Financial Position
The company has a current ratio of 9.48, with a Debt / Equity ratio of 0.19.
| Current Ratio | 9.48 |
| Quick Ratio | 9.30 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.18 |
| Interest Coverage | -13.01 |
Financial Efficiency
Return on equity (ROE) is 14.03% and return on invested capital (ROIC) is -8.08%.
| Return on Equity (ROE) | 14.03% |
| Return on Assets (ROA) | -5.32% |
| Return on Invested Capital (ROIC) | -8.08% |
| Return on Capital Employed (ROCE) | -8.68% |
| Revenue Per Employee | $828,113 |
| Profits Per Employee | $302,515 |
| Employee Count | 97 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TBPH has paid $17.90 million in taxes.
| Income Tax | 17.90M |
| Effective Tax Rate | 37.88% |
Stock Price Statistics
The stock price has increased by +93.43% in the last 52 weeks. The beta is 0.14, so TBPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | +93.43% |
| 50-Day Moving Average | 15.88 |
| 200-Day Moving Average | 12.07 |
| Relative Strength Index (RSI) | 57.76 |
| Average Volume (20 Days) | 607,086 |
Short Selling Information
The latest short interest is 5.46 million, so 10.77% of the outstanding shares have been sold short.
| Short Interest | 5.46M |
| Short Previous Month | 5.08M |
| Short % of Shares Out | 10.77% |
| Short % of Float | 24.41% |
| Short Ratio (days to cover) | 13.52 |
Income Statement
In the last 12 months, TBPH had revenue of $80.33 million and earned $29.34 million in profits. Earnings per share was $0.58.
| Revenue | 80.33M |
| Gross Profit | 40.82M |
| Operating Income | -32.81M |
| Pretax Income | 47.24M |
| Net Income | 29.34M |
| EBITDA | -31.16M |
| EBIT | -32.81M |
| Earnings Per Share (EPS) | $0.58 |
Full Income StatementBalance Sheet
The company has $329.68 million in cash and $44.60 million in debt, giving a net cash position of $288.11 million or $5.69 per share.
| Cash & Cash Equivalents | 329.68M |
| Total Debt | 44.60M |
| Net Cash | 288.11M |
| Net Cash Per Share | $5.69 |
| Equity (Book Value) | 232.68M |
| Book Value Per Share | 4.59 |
| Working Capital | 317.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $243.70 million and capital expenditures -$224,000, giving a free cash flow of $243.48 million.
| Operating Cash Flow | 243.70M |
| Capital Expenditures | -224,000 |
| Free Cash Flow | 243.48M |
| FCF Per Share | $4.80 |
Full Cash Flow StatementMargins
Gross margin is 50.82%, with operating and profit margins of -40.85% and 36.53%.
| Gross Margin | 50.82% |
| Operating Margin | -40.85% |
| Pretax Margin | 58.81% |
| Profit Margin | 36.53% |
| EBITDA Margin | -38.80% |
| EBIT Margin | -40.85% |
| FCF Margin | 303.11% |
Dividends & Yields
TBPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.49% |
| Shareholder Yield | -3.49% |
| Earnings Yield | 3.12% |
| FCF Yield | 25.90% |
Analyst Forecast
The average price target for TBPH is $27.80, which is 49.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.80 |
| Price Target Difference | 49.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 31.53% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TBPH has an Altman Z-Score of -0.59 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.59 |
| Piotroski F-Score | 6 |